C Mallikarjuna Rao Selected Research

C Mallikarjuna Rao Research Topics

Disease

9	Neoplasms (Cancer) 01/2020 - 03/2012
4	Inflammation (Inflammations) 10/2021 - 01/2006
4	Colonic Neoplasms (Colon Cancer) 01/2018 - 01/2014
3	Wounds and Injuries (Trauma) 01/2011 - 01/2006
2	Non-alcoholic Fatty Liver Disease 07/2022 - 01/2021
2	Body Weight (Weight, Body) 10/2021 - 06/2013
2	Alzheimer Disease (Alzheimer's Disease) 01/2021 - 12/2013
2	Cognitive Dysfunction 01/2021 - 10/2020
2	Neuroinflammatory Diseases 10/2019 - 10/2016
2	Colorectal Neoplasms (Colorectal Cancer) 01/2018 - 01/2017
2	Carcinogenesis 05/2017 - 03/2012
2	Adenocarcinoma 01/2017 - 05/2015
2	Aberrant Crypt Foci 01/2017 - 01/2014
2	Breast Neoplasms (Breast Cancer) 01/2017 - 06/2015
2	Carcinoma (Carcinomatosis) 01/2017 - 03/2012
1	Alcoholic Fatty Liver 07/2022
1	COVID-19 10/2021
1	Memory Disorders (Memory Loss) 01/2021
1	Amnesia (Dissociative Amnesia) 01/2021
1	Glioblastoma (Glioblastoma Multiforme) 10/2020
1	Chemotherapy-Related Cognitive Impairment 10/2020
1	Glioma (Gliomas) 10/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2020
1	Weight Loss (Weight Reduction) 10/2019
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 10/2019
1	Stroke (Strokes) 10/2019
1	Major Depressive Disorder (Major Depressive Disorders) 08/2019
1	Pain (Aches) 08/2016
1	Disease Progression 08/2016
1	Arthritis (Polyarthritis) 08/2016
1	Polyps 01/2014
1	Dementia (Dementias) 12/2013
1	Hyperlipidemias (Hyperlipidemia) 06/2013

Drug/Important Bio-Agent (IBA)

4	EnzymesIBA 10/2018 - 05/2015
3	SulfonamidesIBA 07/2022 - 05/2015
3	Dimenhydrinate (DMH)FDA LinkGeneric 01/2017 - 01/2014
3	hydrazine (hydrazine dihydrochloride)IBA 01/2017 - 01/2014
2	Triglycerides (Triacylglycerol)IBA 07/2022 - 06/2013
2	Metformin (Glucophage)FDA LinkGeneric 01/2021 - 10/2019
2	LipopolysaccharidesIBA 10/2019 - 10/2016
2	Histone Deacetylases (Histone Deacetylase)IBA 01/2018 - 06/2016
2	Annexin A5IBA 01/2017 - 06/2015
2	ChalconesIBA 01/2017 - 01/2017
2	caffeic acidIBA 10/2016 - 12/2013
2	cinnamic acidIBA 06/2016 - 05/2015
2	sesamolIBA 06/2013 - 01/2011
2	Hydroxyproline (4 Hydroxyproline)IBA 01/2011 - 08/2008
2	Ketamine FDA LinkGeneric 01/2011 - 08/2008
1	Nonesterified Fatty Acids (NEFA)IBA 07/2022
1	LipidsIBA 07/2022
1	Messenger RNA (mRNA)IBA 10/2021
1	IsocoumarinsIBA 10/2021
1	Scopolamine (Hyoscine)FDA Link 01/2021
1	Colchicine FDA LinkGeneric 01/2021
1	Cholinergic Agents (Cholinergics)IBA 01/2021
1	Rivastigmine (Exelon)FDA LinkGeneric 01/2021
1	Amyloid (Amyloid Fibrils)IBA 01/2021
1	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2021
1	SilymarinIBA 01/2021
1	Liposomes (Liposome)IBA 01/2021
1	ThiazolidinedionesIBA 01/2021
1	Temozolomide (Temodar)FDA LinkGeneric 10/2020
1	methyl-3-methoxy-4-hydroxystyryl ketoneIBA 10/2020
1	Cytotoxins (Cytolysins)IBA 09/2020
1	benzothiazoleIBA 01/2020
1	Neuroprotective AgentsIBA 10/2019
1	BiguanidesIBA 10/2019
1	Catechin (Z 7300)IBA 08/2019
1	Pharmaceutical PreparationsIBA 10/2018
1	Histone Deacetylase InhibitorsIBA 01/2018
1	3-hydroxyflavoneIBA 01/2018
1	FlavonolsIBA 01/2018
1	Nucleosomes (Nucleosome)IBA 05/2017
1	MicroRNAs (MicroRNA)IBA 05/2017
1	Ethidium (Ethidium Bromide)IBA 01/2017
1	Acridine OrangeIBA 01/2017
1	Chalcone (Benzalacetophenone)IBA 01/2017
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017
1	Coloring Agents (Dyes)IBA 01/2017
1	FlavonoidsIBA 01/2017
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 01/2017
1	Propidium (Propidium Iodide)IBA 01/2017
1	Therapeutic UsesIBA 08/2016
1	CytokinesIBA 08/2016
1	ProstaglandinsIBA 08/2016
1	Caspase 3 (Caspase-3)IBA 06/2015
1	NitritesIBA 05/2015
1	NitratesIBA 05/2015
1	Interleukin-6 (Interleukin 6)IBA 05/2015
1	Aluminum ChlorideIBA 12/2013
1	AluminumIBA 12/2013
1	ChloridesIBA 12/2013
1	sesamolinIBA 06/2013
1	Niacin (Nicotinic Acid)FDA LinkGeneric 06/2013
1	CholesterolIBA 06/2013
1	Cholic AcidIBA 06/2013
1	Coconut OilIBA 06/2013

Therapy/Procedure

3	Therapeutics 01/2021 - 10/2018
2	Drug Therapy (Chemotherapy) 01/2020 - 05/2017
1	Diet Therapy (Therapy, Diet) 01/2021